Metraipolis › archive › dc_91fa3d3aff1b

Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center — Europe PMC PMID:41020868

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41020868
DOI
10.3390/cimb47090746
License (as archived)
solo-consultazione
Archived
2026-11-10T00:46:18.842Z
SHA-256 of the archived text
262de22c88c8d3d9d76ede4ba036599ab84adc863d7300090a122624ef22f7e3
Stable URL of this page
https://metraipolis.com/documento/dc_91fa3d3aff1b

How to cite

Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center — Europe PMC PMID:41020868 — Europe PMC (en), https://europepmc.org/article/MED/41020868 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_91fa3d3aff1b (Metraipolis archive dc_91fa3d3aff1b, sha256 262de22c88c8d3d9d76ede4ba036599ab84adc863d7300090a122624ef22f7e3)
BibTeX
@misc{dc91fa3d3aff1b,
  title = {Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center — Europe PMC PMID:41020868},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41020868},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_91fa3d3aff1b; sha256 262de22c88c8d3d9d76ede4ba036599ab84adc863d7300090a122624ef22f7e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41020868. Agents can read the archived copy with the MCP tool read_document.